Gynecological Cancer
Practical Radiation Oncology
AMA PRA Category 1 Credits 1.25
CAMPEP Credits: 1.25
MDCB Credits: 1.25
Elizabeth Kidd, MD
Stanford University
Stanford, CA, United States
Malolan Rajagopalan, MD, MBA
Mount Carmel Health System
Grove City, OH
Using a multidisciplinary case-based approach, this session will discuss recent studies important for the management of gynecologic cancer. The session will include a gynecologic pathologist for review and discussion of the significance of recent additions to gynecologic pathology reports that are becoming more common, including the four molecular groups and extent of lymphovascular invasion (LVI) for endometrial cancer, HPV status for vulvar cancer, and PD-L1 expression for cervical cancer. The endometrial case discussion will highlight the updates in FIGO staging with the inclusion of molecular status and LVI, emerging data suggesting molecular status should influence treatment approach for endometrial cancers and role of immunotherapy for advanced stage disease. The vulvar and cervical cancer case discussions will highlight how to use pathologic features, such as HPV status and PD-L1 expression to help guide treatment approach. Additionally, how to interpret recently reported contrasting data, in particular for immunotherapy and neoadjuvant chemotherapy, for locally advanced cervical cancer will be reviewed to help optimize patient selection for these new treatment approaches for definitive management.
Speaker: Elizabeth Kidd, MD – Stanford University
Speaker: Taylor Jenkins, MD – Virginia Commonwealth University
Speaker: Susan Gueble, MD, PhD – Yale University School of Medicine
Speaker: Junzo Chino, MD, FASTRO – Duke Cancer Institute
Speaker: Malolan Rajagopalan, MD, MBA – Mount Carmel Health System